Inhibition of translocator protein 18 kDa suppressed the progression of glioma via the ELAV-like RNA-binding protein 1/MAPK-activated protein kinase 3 axis

Glioma is the most common primary malignant brain tumors in adults. Despite considerable advances in treatment, the clinical outcome remains dismal. Translocator protein 18 kDa (TSPO), an evolutionarily conserved transmembrane protein, has always been found to be elevated in glioma, which predicts a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingya, Ren, Peng, Zeng, Zhirui, Ma, Li, Li, Yunjun, Zhang, Hongmei, Guo, Wenzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208533/
https://www.ncbi.nlm.nih.gov/pubmed/35285415
http://dx.doi.org/10.1080/21655979.2022.2048992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208533/
https://www.ncbi.nlm.nih.gov/pubmed/35285415
http://dx.doi.org/10.1080/21655979.2022.2048992

Ejemplares similares